Jersey City Medical Center, an RWJBarnabas Health facility, has reached a critical medical milestone in its Neonatal Intensive Care Unit (NICU).
From October 2014 through October 2019, the hospital’s NICU had zero cases of central line-associated bloodstream infection (CLABSI), achieving the rare distinction of being “CLABSI-free” for six years.
CLABSIs are primary bloodstream infections that are associated with the presence of a central vascular catheter, a tube that is placed into a patient’s large vein, usually in the neck, chest, arm or leg, to give fluids and medication, withdraw blood, and monitor the patient’s condition.
CLABSI is a significant contributor to morbidity and mortality for infants, a population specifically susceptible to infections because of immature immune system.
“Jersey City Medical Center is proud of this achievement, and of our entire Maternal, Child Health and NICU team,” said Michael Prilutsky, president and CEO. “Our goal is always to provide the highest level of safety and care to all our patients, especially to the most vulnerable ones in our care.”
Jersey City Medical Center is a state-designated regional perinatal center. The hospital’s NICU is the only Level 3 and the highest level NICU in Hudson County with 24/7 coverage by board-certified neonatologists.
Last year, the NICU cared for over 350 babies, weighting as little as just under a pound and as many as quintuplets born 13 weeks early. The hospital also has one of the state’s only NicView™ system – an innovative webcam system, which offers secure viewing of NICU to families worldwide.
Jersey City Medical Center is scheduled to open the Lord Abbett Maternity Wing in January 2020, which will add 20 private mother-baby rooms to the existing maternity units. To schedule a tour, visit rwjbh.org/maternity.